MAKING PAIN HISTORY®
Neuromed is a biopharmaceutical company developing new and improved pain therapies. Our goal is to create a better future for people who suffer from chronic pain. | JUL-02-2009 COMBINATORX AND NEUROMED SIGN MERGER AGREEMENT
JUN-17-2009 Neuromed Announces Sale of U.S. Rights to Drug Candidate Exalgo™(hydromorphone HCl) Extended-Release Tablets (CII)
JUN-11-2009 Neuromed Announces that Merck & Co., Inc. Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels
MAR-23-2009 Neuromed Announces Exalgo (hydromorphone HCl) Extended-Release Tablets (CII) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial
|
